FANCE Polyclonal Antibody

Background:
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group E.

Research Area: Epigenetics and Nuclear Signaling

Synonyms:
2810451D06Rik , AI415634, AW209126, FACE, FAE, FANCE, FANCE, Fanconi anemia complementation group E, Fanconi anemia group E protein, OTTHUMP00000016254, Protein FACE, RGD1561045

Immunogen: Synthetic peptide of human FANCE

Swissprot: Q9HB96
Gene Accession: NP068741

Purification Method: Antigen affinity purification

Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4

Concentration: 1.5 mg/mL
Dilution: IHC 1:40-1:200, ELISA 1:5000-1:10000

Storage:
Store at -20°C. Avoid freeze / thaw cycles.